| 摘要 |
<p>The invention relates to a medical analysis system (100) comprising a first interface (112) being operable for receiving an antigen level, wherein the antigen level is a prostate-specific antigen, PSA, level, a second interface (110) being operable for receiving an FUT genotype, an first assigning module (114) being operable for assigning the FUT genotype to a genotype group type of a set of predefined genotype group types, said assigning resulting in an assigned genotype group type, a selection module (116) comprising an association of an antigen threshold level to each genotype group type of the set of predefined genotype group types, wherein the antigen threshold level is a PSA threshold level, wherein the selection module (116) is operable for determining from the association the antigen threshold level associated with the assigned genotype group type and for determining if the antigen level is above the determined antigen threshold level, - a third interface (118) being operable for providing an indication on a risk for prostate cancer in case the antigen level is above the determined antigen threshold level.</p> |
